GlobeNewswire

QUANTRO Therapeutics secures key Austrian research grant to build its AI-powered drug discovery platform
03/11/2026
Austrian Research Promotion Agency FFG awards funding to QUANTRO to develop and implement ASCEND, an integrated artificial intelligence platform for transcription factor drug discovery Vienna, Austria, Nov. 03, 2026 ( [...]
Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22%
03/11/2026
Internet, Everywhere, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Shopify announced today financial results for the quarter ended September 30, 2026. Shopify achieved 32% revenue growth (32% in constant currency) and a 22% free [...]
BlossomHill Therapeutics to Present at Guggenheim’s 3rd Annual Healthcare Innovations Conference
03/11/2026
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative [...]
Dr. Oetker lance la cinquième édition de Giuseppe Entraîne-toi avec un pro et accueille P.K. Subban comme nouvel ambassadeur
03/11/2026
L'ancien joueur vedette de la LNH et figure bien connue des Québécois rejoint cette nouvelle édition du programme, qui célèbre les équipes de hockey mineur ayant un impact positif dans leur communauté. TORONTO, 03 nov. [...]
Dr. Oetker Launches Fifth Year of Giuseppe Practice with a Pro, Welcomes P.K. Subban as the Program’s New Ambassador
03/11/2026
The Canadian hockey icon joins the next chapter of the community-based program, celebrating minor hockey teams that are making a difference in their communities TORONTO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Dr. Oetker [...]
Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities
03/11/2026
Acquisition significantly expands the depth and scale of Evestia Clinical’s established medical writing capabilities for biotech innovators and pharmaceutical companies The deal expands Evestia Clinical’s European [...]
Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference
03/11/2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX) today announced that Malte Peters, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a [...]
Jade Biosciences to Participate in Upcoming Conferences
03/11/2026
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in- [...]
Rapport Therapeutics to Participate in Upcoming Investor Conferences
03/11/2026
BOSTON and SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer
03/11/2026
Neil joins from Novo Nordisk and brings more than 20 years of experience in business development and strategic transactions Appointment strengthens MitoRx’s business development capabilities as the Company advances [...]
Pasithea Therapeutics Announces FDA Clearance of IND for PAS-004 in Neurofibromatosis Type 1 (NF1)-Associated Cutaneous Neurofibromas (cNF)
03/11/2026
— FDA clearance allows Pasithea to advance PAS-004 for NF1-associated cNF, a condition affecting over 95% of people with NF1 and for which there are currently no FDA-approved systemic therapies . — MIAMI, Nov. 03, 2026 [...]
Axsome Therapeutics to Participate in Upcoming Investor Conferences
03/11/2026
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it [...]
Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026
03/11/2026
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood [...]
Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion
03/11/2026
COMPANY STRENGTHENS NEUROSCIENCE LEADERSHIP WITH WELTRUZA™ LAUNCH AND STRATEGIC ADDITION OF BXCL-501 Q3 2026 revenues of $4.4 billion , a decrease of 2% year-over-year in both U.S. dollars and local currency terms, [...]
ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026
03/11/2026
Company to host investor conference call and webcast at 4:30 p.m. ET. Cambridge, Massachusetts, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company [...]
Cartesian Therapeutics Announces New Employment Inducement Grant
03/11/2026
FREDERICK, Md., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced [...]
Opus Genetics to Present at the Guggenheim Annual Healthcare Innovation Conference
03/11/2026
RESEARCH TRIANGLE PARK, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Parabilis Medicines to Participate in Upcoming November Investor Conferences
03/11/2026
CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by [...]
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in November
03/11/2026
WATERTOWN, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a biotechnology company pioneering a new class of medicines against challenging targets in oncology and immunology & [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum